Tags

Type your tag names separated by a space and hit enter

Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab.
Kidney Int. 2020 08; 98(2):508-509.KI

Authors+Show Affiliations

Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France; Institut national de la santé et de la recherche médical, immunorhumatologie moléculaire unité mixte de recherche-S 1109, Strasbourg, France. Electronic address: gabriela.gautier-vargas@chru-strasbourg.fr.Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France; Institut national de la santé et de la recherche médical, immunorhumatologie moléculaire unité mixte de recherche-S 1109, Strasbourg, France; Department of Virology, Strasbourg University Hospital, Strasbourg, France.Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France; Institut national de la santé et de la recherche médical, immunorhumatologie moléculaire unité mixte de recherche-S 1109, Strasbourg, France.Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France; Institut national de la santé et de la recherche médical, immunorhumatologie moléculaire unité mixte de recherche-S 1109, Strasbourg, France.Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France; Institut national de la santé et de la recherche médical, immunorhumatologie moléculaire unité mixte de recherche-S 1109, Strasbourg, France.

Pub Type(s)

Case Reports
Letter

Language

eng

PubMed ID

32505467

Citation

Gautier-Vargas, Gabriela, et al. "Rapid Resolution of Cytokine Release Syndrome and Favorable Clinical Course of Severe COVID-19 in a Kidney Transplant Recipient Treated With Tocilizumab." Kidney International, vol. 98, no. 2, 2020, pp. 508-509.
Gautier-Vargas G, Baldacini C, Benotmane I, et al. Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab. Kidney Int. 2020;98(2):508-509.
Gautier-Vargas, G., Baldacini, C., Benotmane, I., Keller, N., Perrin, P., Moulin, B., & Caillard, S. (2020). Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab. Kidney International, 98(2), 508-509. https://doi.org/10.1016/j.kint.2020.05.022
Gautier-Vargas G, et al. Rapid Resolution of Cytokine Release Syndrome and Favorable Clinical Course of Severe COVID-19 in a Kidney Transplant Recipient Treated With Tocilizumab. Kidney Int. 2020;98(2):508-509. PubMed PMID: 32505467.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab. AU - Gautier-Vargas,Gabriela, AU - Baldacini,Clement, AU - Benotmane,Ilies, AU - Keller,Nicolas, AU - Perrin,Peggy, AU - Moulin,Bruno, AU - Caillard,Sophie, Y1 - 2020/06/04/ PY - 2020/05/19/received PY - 2020/05/21/accepted PY - 2020/6/9/pubmed PY - 2020/8/5/medline PY - 2020/6/8/entrez SP - 508 EP - 509 JF - Kidney international JO - Kidney Int VL - 98 IS - 2 SN - 1523-1755 UR - https://www.unboundmedicine.com/medline/citation/32505467/Rapid_resolution_of_cytokine_release_syndrome_and_favorable_clinical_course_of_severe_COVID_19_in_a_kidney_transplant_recipient_treated_with_tocilizumab_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0085-2538(20)30622-0 DB - PRIME DP - Unbound Medicine ER -